Pharmaceutical Manufacturing and Supply of Isoniazid Tablets

The contract demands the production and delivery of FDA-approved Isoniazid Tablets, 300 mg, in bottles of 100 units per National Stock Number 6505001326904, encompassing full manufacturing capabilities from formulation through final packaging. All processes must adhere to strict quality control protocols and meet both U.S. Food and Drug Administration standards and U.S. military specifications, ensuring the product is suitable for distribution within Department of Defense medical supply chains. Compliance with regulatory and procedural guidelines for pharmaceuticals intended for military use is mandatory, including documentation, labeling, and lot traceability requirements. The work is to be performed under a subcontract awarded by the Medical Supply Chain Pharm FSA, a division of the Department of Defense, with the place of performance designated as FPO, ZIP 09568. The solicitation was posted on May 11, 2026, and responses are due by May 18, 2026, with the North American Industry Classification System code 325412 identifying it as pharmaceutical and medicine manufacturing. The contract requires the supplier to demonstrate proven experience in scaled production of active pharmaceutical ingredients and finished dosage forms under cGMP conditions, with the capability to meet DoD logistics timelines and performance benchmarks for emergency or operational deployments.